Related Experiment Video
Updated: Aug 4, 2026

Gastrointestinal Motility Monitor (GIMM)
Published on: December 1, 2010
Intraluminal pH modulates gastric prostaglandin synthesis
G H Curtis1, W K MacNaughton, D G Gall
1Intestinal Disease Research Unit, Faculty of Medicine, University of Calgary, AB, Canada.
Gastric intraluminal pH significantly impacts prostaglandin E2 synthesis in rats. High pH reduces synthesis, while low pH increases it, suggesting a protective role for prostaglandins.
Area of Science:
- Gastroenterology
- Physiology
- Biochemistry
Background:
- Prostaglandins are crucial for gastric mucosal integrity and acid secretion.
- Regulation of prostaglandin synthesis within the stomach remains poorly understood.
Purpose of the Study:
- To investigate the effect of varying gastric intraluminal pH on prostaglandin E2 synthesis in gastric tissue.
- To determine if changes in pH trigger a physiological response to maintain gastric health.
Main Methods:
- Oral administration of solutions with different pH levels (1, 3, 8.3, 10) to rats.
- Measurement of prostaglandin E2 and leukotriene B4 synthesis capacity in gastric tissue.
- Subcutaneous administration of solutions to control for systemic effects.
Main Results:
- Oral administration of high pH (8.3, 10) solutions significantly reduced prostaglandin E2 synthesis.
- Oral administration of a low pH (1) solution significantly increased prostaglandin E2 synthesis.
- Neither high nor low pH affected leukotriene B4 synthesis; effects were pH-dependent and not due to osmolarity.
Conclusions:
- Gastric intraluminal pH directly influences the capacity of gastric tissue to synthesize prostaglandin E2.
- This pH-mediated regulation may serve as a protective mechanism for gastric mucosa during low pH conditions.
- Findings suggest a feedback loop where pH affects prostaglandin synthesis, potentially modulating gastric acid secretion.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Intestinal Phase of Digestion
The arrival of the chyme in the small intestine distends the duodenum, which triggers the enterogastric reflex. This distension...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...

